Alexander Nowak
Stock Analyst at Craig-Hallum
(2.70)
# 1,909
Out of 5,115 analysts
46
Total ratings
45.95%
Success rate
7.14%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $109.42 | -1.30% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $6.85 | +221.17% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $231.14 | -32.08% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.93 | +114.38% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.17 | +109.79% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.55 | -27.01% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $8.04 | -0.50% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.64 | +997.56% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $19.89 | +151.38% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $10.02 | +1,496.81% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $102.34 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.89 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.19 | +402.28% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $64.09 | +71.63% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $7.33 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.62 | +18,418.52% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.26 | +238.98% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $109.42
Upside: -1.30%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $6.85
Upside: +221.17%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $231.14
Upside: -32.08%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.93
Upside: +114.38%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.17
Upside: +109.79%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.55
Upside: -27.01%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $8.04
Upside: -0.50%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.64
Upside: +997.56%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $19.89
Upside: +151.38%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $10.02
Upside: +1,496.81%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $102.34
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.89
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.19
Upside: +402.28%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $64.09
Upside: +71.63%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $7.33
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.62
Upside: +18,418.52%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.26
Upside: +238.98%